The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antibody Conjugation and Labeling Services Market Research Report 2025

Global Antibody Conjugation and Labeling Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1893336

No of Pages : 105

Ask Your Query
Synopsis
Antibody conjugation and labeling services refer to specialized laboratory services that use various techniques to attach various substances, such as fluorescent dyes, radioactive isotopes, or small molecules, to antibodies for specific labeling and detection purposes. These services typically involve the preparation of antibodies, selection of appropriate labeling reagents, and optimization of labeling conditions to ensure high-quality labeling with desired characteristics. The services are commonly used for research applications such as flow cytometry, immunofluorescence, and immunohistochemistry, where antibodies are used to identify and characterize cells or tissue samples.
The global Antibody Conjugation and Labeling Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for antibody conjugation and labeling services is experiencing significant growth due to the increasing demand for label-free and high-throughput detection methods in research and clinical settings. With the advancements in optical and mass spectrometry technologies, there is a growing need for more sensitive and specific labeling methods that can be applied in high-content screening and precision medicine settings. Additionally, the trend towards personalized and precision medicine is fueling the demand for antibody labeling services that enable the development of targeted therapies tailored to individual patients' needs. Furthermore, the growing use of antibody-based drugs in oncology and other diseases is driving the need for more advanced antibody labeling capabilities, thus contributing to the growth of this industry trend.
This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation and Labeling Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation and Labeling Services.
Report Scope
The Antibody Conjugation and Labeling Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Conjugation and Labeling Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation and Labeling Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Beijing Abace Biotechnology
Segment by Type
Antibody Conjugation Services
Antibody Labeling Services
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Conjugation and Labeling Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Conjugation and Labeling Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody Conjugation Services
1.2.3 Antibody Labeling Services
1.3 Market by Application
1.3.1 Global Antibody Conjugation and Labeling Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Conjugation and Labeling Services Market Perspective (2019-2030)
2.2 Antibody Conjugation and Labeling Services Growth Trends by Region
2.2.1 Global Antibody Conjugation and Labeling Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Conjugation and Labeling Services Historic Market Size by Region (2019-2024)
2.2.3 Antibody Conjugation and Labeling Services Forecasted Market Size by Region (2025-2030)
2.3 Antibody Conjugation and Labeling Services Market Dynamics
2.3.1 Antibody Conjugation and Labeling Services Industry Trends
2.3.2 Antibody Conjugation and Labeling Services Market Drivers
2.3.3 Antibody Conjugation and Labeling Services Market Challenges
2.3.4 Antibody Conjugation and Labeling Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Conjugation and Labeling Services Players by Revenue
3.1.1 Global Top Antibody Conjugation and Labeling Services Players by Revenue (2019-2024)
3.1.2 Global Antibody Conjugation and Labeling Services Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Conjugation and Labeling Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Conjugation and Labeling Services Revenue
3.4 Global Antibody Conjugation and Labeling Services Market Concentration Ratio
3.4.1 Global Antibody Conjugation and Labeling Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Conjugation and Labeling Services Revenue in 2023
3.5 Antibody Conjugation and Labeling Services Key Players Head office and Area Served
3.6 Key Players Antibody Conjugation and Labeling Services Product Solution and Service
3.7 Date of Enter into Antibody Conjugation and Labeling Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Conjugation and Labeling Services Breakdown Data by Type
4.1 Global Antibody Conjugation and Labeling Services Historic Market Size by Type (2019-2024)
4.2 Global Antibody Conjugation and Labeling Services Forecasted Market Size by Type (2025-2030)
5 Antibody Conjugation and Labeling Services Breakdown Data by Application
5.1 Global Antibody Conjugation and Labeling Services Historic Market Size by Application (2019-2024)
5.2 Global Antibody Conjugation and Labeling Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Conjugation and Labeling Services Market Size (2019-2030)
6.2 North America Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Conjugation and Labeling Services Market Size by Country (2019-2024)
6.4 North America Antibody Conjugation and Labeling Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Conjugation and Labeling Services Market Size (2019-2030)
7.2 Europe Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Conjugation and Labeling Services Market Size by Country (2019-2024)
7.4 Europe Antibody Conjugation and Labeling Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Conjugation and Labeling Services Market Size (2019-2030)
8.2 Asia-Pacific Antibody Conjugation and Labeling Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Conjugation and Labeling Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Conjugation and Labeling Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Conjugation and Labeling Services Market Size (2019-2030)
9.2 Latin America Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Conjugation and Labeling Services Market Size by Country (2019-2024)
9.4 Latin America Antibody Conjugation and Labeling Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Conjugation and Labeling Services Market Size (2019-2030)
10.2 Middle East & Africa Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Conjugation and Labeling Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Conjugation and Labeling Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProSci, Inc
11.1.1 ProSci, Inc Company Detail
11.1.2 ProSci, Inc Business Overview
11.1.3 ProSci, Inc Antibody Conjugation and Labeling Services Introduction
11.1.4 ProSci, Inc Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.1.5 ProSci, Inc Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Antibody Conjugation and Labeling Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Conjugation and Labeling Services Introduction
11.3.4 Abcam Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Antibody Conjugation and Labeling Services Introduction
11.4.4 Cell Signaling Technology Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.4.5 Cell Signaling Technology Recent Development
11.5 Bio X Cell
11.5.1 Bio X Cell Company Detail
11.5.2 Bio X Cell Business Overview
11.5.3 Bio X Cell Antibody Conjugation and Labeling Services Introduction
11.5.4 Bio X Cell Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.5.5 Bio X Cell Recent Development
11.6 SouthernBiotech
11.6.1 SouthernBiotech Company Detail
11.6.2 SouthernBiotech Business Overview
11.6.3 SouthernBiotech Antibody Conjugation and Labeling Services Introduction
11.6.4 SouthernBiotech Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.6.5 SouthernBiotech Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Detail
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Antibody Conjugation and Labeling Services Introduction
11.7.4 Novus Biologicals Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.7.5 Novus Biologicals Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Antibody Conjugation and Labeling Services Introduction
11.8.4 GenScript Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.8.5 GenScript Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Detail
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Antibody Conjugation and Labeling Services Introduction
11.9.4 Leinco Technologies Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.9.5 Leinco Technologies Recent Development
11.10 Standard BioTools
11.10.1 Standard BioTools Company Detail
11.10.2 Standard BioTools Business Overview
11.10.3 Standard BioTools Antibody Conjugation and Labeling Services Introduction
11.10.4 Standard BioTools Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.10.5 Standard BioTools Recent Development
11.11 AlphaThera
11.11.1 AlphaThera Company Detail
11.11.2 AlphaThera Business Overview
11.11.3 AlphaThera Antibody Conjugation and Labeling Services Introduction
11.11.4 AlphaThera Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.11.5 AlphaThera Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Detail
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Antibody Conjugation and Labeling Services Introduction
11.12.4 Creative Biolabs Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 Antibodies
11.13.1 Antibodies Company Detail
11.13.2 Antibodies Business Overview
11.13.3 Antibodies Antibody Conjugation and Labeling Services Introduction
11.13.4 Antibodies Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.13.5 Antibodies Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Detail
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Antibody Conjugation and Labeling Services Introduction
11.14.4 Boster Biological Technology Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.14.5 Boster Biological Technology Recent Development
11.15 Cygnus Technologies
11.15.1 Cygnus Technologies Company Detail
11.15.2 Cygnus Technologies Business Overview
11.15.3 Cygnus Technologies Antibody Conjugation and Labeling Services Introduction
11.15.4 Cygnus Technologies Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.15.5 Cygnus Technologies Recent Development
11.16 Cayman Chemical
11.16.1 Cayman Chemical Company Detail
11.16.2 Cayman Chemical Business Overview
11.16.3 Cayman Chemical Antibody Conjugation and Labeling Services Introduction
11.16.4 Cayman Chemical Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.16.5 Cayman Chemical Recent Development
11.17 GeneTex
11.17.1 GeneTex Company Detail
11.17.2 GeneTex Business Overview
11.17.3 GeneTex Antibody Conjugation and Labeling Services Introduction
11.17.4 GeneTex Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.17.5 GeneTex Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Antibody Conjugation and Labeling Services Introduction
11.18.4 ProteoGenix Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Levena Biopharma
11.19.1 Levena Biopharma Company Detail
11.19.2 Levena Biopharma Business Overview
11.19.3 Levena Biopharma Antibody Conjugation and Labeling Services Introduction
11.19.4 Levena Biopharma Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.19.5 Levena Biopharma Recent Development
11.20 Merck
11.20.1 Merck Company Detail
11.20.2 Merck Business Overview
11.20.3 Merck Antibody Conjugation and Labeling Services Introduction
11.20.4 Merck Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.20.5 Merck Recent Development
11.21 Lonza
11.21.1 Lonza Company Detail
11.21.2 Lonza Business Overview
11.21.3 Lonza Antibody Conjugation and Labeling Services Introduction
11.21.4 Lonza Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.21.5 Lonza Recent Development
11.22 Charles River
11.22.1 Charles River Company Detail
11.22.2 Charles River Business Overview
11.22.3 Charles River Antibody Conjugation and Labeling Services Introduction
11.22.4 Charles River Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.22.5 Charles River Recent Development
11.23 Beijing Abace Biotechnology
11.23.1 Beijing Abace Biotechnology Company Detail
11.23.2 Beijing Abace Biotechnology Business Overview
11.23.3 Beijing Abace Biotechnology Antibody Conjugation and Labeling Services Introduction
11.23.4 Beijing Abace Biotechnology Revenue in Antibody Conjugation and Labeling Services Business (2019-2024)
11.23.5 Beijing Abace Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock